Abstract
Drug addiction is a pathophysiological disorder characterized by the progression of acute drug use into patterns of chronic drug abuse associated with craving and seeking behavior as well as increasing risk for relapse in drug use during attempts at withdrawal. Drugs of abuse include a wide variety of substances diverse in structure, pharmacology, toxicology, and long-term clinical sequelae but with the common target of brain reward centers. The authors discuss drugs within each of the major classes of abused substances from the perspectives of the history of each drug’s use as well as chemical properties, mechanisms of action including selective receptor interactions, pharmacokinetics of distribution-metabolism-elimination, and the toxicology of these drugs. The major classes of drug reviewed include the two most commonly used substances, ethanol and tobacco, as well as stimulants, opiates, cannabinoids, hallucinogens, barbiturates, and benzodiazepines.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abrams DI, Hilton JF, Leiser RJ et al (2003) Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med 139:258–266
Abrams DI, Vizoso HP, Shade SB et al (2007) Vaporization as a smokeless cannabis delivery system: a pilot study. Clin Pharmacol Ther 82:572–578
Aceto MD, Harris LS, Abood ME et al (1999) Stereoselective mu- and delta-opioid receptor-related antinociception and binding with (+)-thebaine. Eur J Pharmacol 365:143–147
Aderjan RE, Skopp G (1998) Formation and clearance of active and inactive metabolites of opiates in humans. Ther Drug Monit 20:561–569
Aistrup GL, Marszalec W, Narahashi T (1999) Ethanol modulation of nicotinic acetylcholine receptor currents in cultured cortical neurons. Mol Pharmacol 55:39–49
Aldington S, Harwood M, Cox B et al (2008) Cannabis use and cancer of the head and neck: case-control study. Otolaryngol Head Neck Surg 138:374–380
Allan AM, Harris RA (1986) Anesthetic and convulsant barbiturates alter gamma-aminobutyric acid-stimulated chloride flux across brain membranes. J Pharmacol Exp Ther 238:763–768
Allan AM, Harris RA (1987) Acute and chronic ethanol treatments alter gaba receptor-operated chloride channels. Pharmacol Biochem Behav 27:665–670
Angell M, Kassirer JP (1994) Alcohol and other drugs – toward a more rational and consistent policy. N Engl J Med 331:537–539
Ashton H (2005) The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry 18:249–255
Bagnardi C, Zambon A, Quatto P et al (2004) Flexible meeta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol 159:1077–1086
Bakhit C, Gibb JW (1981) Methamphetamine-induced depression of tryptophan hydroxylase: recovery following acute treatment. Eur J Pharmacol 76:229–233
Bale AS, Tu Y, Carpenter-Hyland EP et al (2005) Alterations in glutamatergic and gabaergic ion channel activity in hippocampal neurons following exposure to the abused inhalant toluene. Neuroscience 130:197–206
Balster RL (1998) Neural basis of inhalant abuse. Drug Alcohol Depend 51:207–214
Barnett G, Hawks R, Resnick R (1981) Cocaine pharmacokinetics in humans. J Ethnopharmacol 3:353–366
Barquin J, de Dios Luna J, Hernandez AF (2008) A controlled study of the time-course of breath alcohol concentration after moderate ingestion of ethanol following a social drinking session. Forensic Sci Int 177:140–145
Benowitz NL (2008) Neurobiology of nicotine addiction: implications for smoking cessation treatment. Am J Med 121:S3–S10
Blednov YA, Stoffel M, Alva H et al (2003) A pervasive mechanism for analgesia: activation of GIRK2 channels. Proc Natl Acad Sci USA 100:277–282
Boettcher C, Fellermeier M, Boettcher C et al (2005) How human neuroblastoma cells make morphine. Proc Natl Acad Sci USA 102:8495–8500
Boffetta P, Hecht S, Gray N et al (2008) Smokeless tobacco and cancer. Lancet Oncol 9:667–675
Borowsky B, Adham N, Jones KA et al (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98:8966–8971
Bortolato M, Mangieri RA, Fu J et al (2007) Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol Psychiatry 62: 1103–1110
Bowen SE, Batis JC, Paez-Martinez N et al (2006) The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies. Neurotoxicol Teratol 28:636–647
Bracken MB, Eskenazi B, McSharry J-E et al (1990) Association of cocaine use with sperm concentration, motility, and morphology. Fertility Sterility 53:315–322
Branchek TA, Blackburn TP (2003) Trace amine receptors as targets for novel therapeutics: legend, myth and fact. Curr Opin Pharmacol 3:90–97
Brenneisen R (2002) Pharmacokinetics. In: Grotenhermen F, Russo E (eds) Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential. Hayworth Integrative Healing, Binghamton, NY, pp 67–73
Brownstein MJ (1993) A brief history of opiates, opioid peptides, and opioid receptors. Proc Natl Acad Sci USA 90:5391–5393
Budney AJ, Roffman R, Stephens RS et al (2007) Marijuana dependence and its treatment. Addict Sci Clin Pract 4:4–16
Caine SB, Heinrichs SC, Coffin VL et al (1995) Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res 692:47–56
Caine SB, Koob GF (1994) Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270:209–218
Caine SB, Thomsen M, Gabriel KI et al (2007) Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J Neurosci 27:13140–13150
Calatayud J, Gonzalez A (2003) History of the development and evolution of local anesthesia since the coca leaf [see comment]. Anesthesiology 98:1503–1508
Callahan PM, De la GR, Cunningham KA (1994) Discriminative stimulus properties of cocaine: modulation by dopamine D1 receptors in the nucleus accumbens. Psychopharmacology 115:110–114
Catassi A, Servent D, Paleari L et al (2008) Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutat Res 659:221–231
Chait LD, Evans SM, Grant KA et al (1988) Discriminative stimulus and subjective effects of smoked marijuana in humans. Psychopharmacology (Berl) 94:206–212
Chan GC, Hinds TR, Impey S et al (1998) Hippocampal neurotoxicity of Delta9- tetrahydrocannabinol. J Neurosci 18:5322–5332
Chao C, Jacobson LP, Tashkin D et al (2008) Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men. Drug Alcohol Depend 94:165–171
Chaudhry IA, Turkanis SA, Karler R (1988) Characteristics of “reverse tolerance” to amphetamine-induced locomotor stimulation in mice. Neuropharmacology 27:777–781
Cincotta SL, Yorek MS, Moschak TM et al (2008) Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction. Curr Opin Invest Drugs 9:47–56
Cochin J, Woods LA, Seevers MH (1951) The absorption, distribution and urinary excretion of mescaline in the dog. J Pharmacol Exp Ther 101:205–209
Cocores JA, Dackis CA, Gold MS (1986) Sexual dysfunction secondary to cocaine abuse in two patients. J Clin Psychiatry 47:384–385
Colado MI, O’Shea E, Granados R et al (1997) In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA (’ecstasy’) and p-chloroamphetamine but not the degeneration following fenfluramine. Br J Pharmacol 121:889–900
Colasanti BK, Craig CR, Allara RD (1984) Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol. Exp Eye Res 39:251–259
Compton DR, Bagley RB, Katzen JS et al (1987) (+)- and (-)-N-allylnormetazocine binding sites in mouse brain: in vitro and in vivo characterization and regional distribution. Life Sci 40:2195–2206
Connell PH (1968) The use and abuse of amphetamines. Practitioner 200:234–243
Cooke AR, Birchall MB, Birchall A (1969) Absorption of ethanol from the stomach. Gastroenterology 57:269–272
Corrao G, Bagnardi C, Zambon A et al (2004) A meta-analysis of alcohol consumption and the risk of 15 diseases. Preventive Med 38:613–619
Cruz SL, Mirshahi T, Thomas B et al (1998) Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 286:334–340
Cubells JF, Rayport S, Rajendran G et al (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 14:2260–2271
Cunningham ET, Paris JM, Goeders NE (1992) Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding. Synapse 11:112–123
Dalal PM (2001) Ischaemic strokes: management in first six hours. Neurol India 49:104–115
Dar R, Frenk H (2007) Reevaluating the nicotine delivery kinetics hypothesis. Psychopharmacology (Berl) 192:1–7
Deitrich RA, Dunwiddie TV, Harris RA et al (1989) Mechanism of action of ethanol: initial central nervous system actions. Pharmacol Rev 41:489–537
Del AA, Gonzalez-Mora JL, Armas VR et al (1999) Amphetamine increases the extracellular concentration of glutamate in striatum of the awake rat: involvement of high affinity transporter mechanisms. Neuropharmacology 38:943–954
Demisch L, Kaczmarczyk P, Seiler N (1978) 3,4,5-Trimethoxybenzoic acid, a new mescaline metabolite in humans. Drug Metabol Disposition 6:507–509
Derlet RW, Rice P, Horowitz BZ et al (1989) Amphetamine toxicity: experience with 127 cases. J Emergency Med 7:157–161
Devenyi P, Wilson M (1971) Barbiturate abuse and addiction and their relationship to alcohol and alcoholism. Can Med Assoc J 104:215–218
Diaz J (1996) How drugs influence behavior. Prentice Hall, Englewood Cliffs, NJ
Dishotsky NI, Loughman WD, Mogar RE et al (1971) LSD and genetic damage. Science 172:431–440
Doble A, Martin IL (1992) Multiple benzodiazepine receptors: no reason for anxiety. Trends Pharmacol Sci 13:76–81
Drevets WC, Gautier C, Price JC et al (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49:81–96
Edeleanu L (1887) Uber einige derivate der Phenylmethacrylsaure und der Phenylisobutter-saure. Ber Deutsch Chem Ges 20:616–622
Eisenberg MJ, Filion KB, Yavin D et al (2008) Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ 179:135–144
El-Seedi HR, DeSmet PA, Beck O et al (2005) Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archeological specimens of Lophophora from Texas. J Ethnopharmacol 101:238–242
Ellison JM, Dobies DF (1984) Methamphetamine abuse presenting as dysuria following urethral insertion of tablets. Ann Emergency Med 13:198–200
ElSohly MA (2002) Chemical contituents of cannabis. In: Grotenhermen F, Russo E (eds) Cannabis and cannabinoids. Hayworth Integrative Healing, Binghamton, NY, pp 27–37
Enoch M-A (2008) Review: the role of GABAA receptors in the development of alcoholism. Pharmacol Biochem Behav 90:95–104
Espiard ML, Lecardeur L, Abadie P et al (2005) Hallucinogen persisting perception disorder after psilocybin consumption: a case study. Eur Psychiatry: J Assoc Eur Psychiatrists 20:458–460
Fankhauser M (2002) History of cannabis in western medicine. In: Grotenhermen F, Russo E (eds) Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential. Hayworth Integrative Healing, Binghamton, NY, pp 37–53
Ffrench-Mullen JM, Barker JL, Rogawski MA (1993) Calcium current block by (–)–pentobarbital, phenobarbital, and CHEB but not (+)-pentobarbital in acutely isolated hippocampal CA1 neurons: comparison with effects on GABA-activated Cl− current. J Neurosci 13:3211–3221
Finch JE, Kendall MJ, Mitchard M (1974) An assessment of gastric emptying by breathalyser. Br J Clin Pharmacol 1:233–236
Fines RE, Brady WJ, DeBehnke DJ (1997) Cocaine-associated dystonic reaction. Am J Emergency Medi 15:513–515
Flemming KD, Brown RDJ (2004) Secondary prevention strategies in ischemic stroke: identification and optimal management of modifiable risk factors. Mayo Clin Proc 79:1330–1340
Freud S (1884) Centralblatt für die ges. 2. Therapie 289–314
Gardner AJ (1967) Withdrawal fits in barbiturate addicts. Lancet 2:337–338
Gately I (2008) Drink: a cultural history of alcohol. Gotham Books, New York, NY
Gelkopf M, Bleich A, Hayward R et al (1999) Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic. Drug Alcohol Depend 55:63–68
Georgieva T, Devanathan S, Stropova D et al (2008) Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling. Eur J Pharmacol 581:19–29
Gerevich J, Bacskai E, Farkas L et al (2005) A case report: pavlovian conditioning as a risk factor in heroin ‘overdose’ death. Harm Reduction J 2:11–14
Ghajanian GK, Bing OH (1964) Persistence of lysergic acid diethylamide in the plasma of human subjects. Clin Pharmacol Therap 5:611–614
Gieringer D (1996) Marijuana research: waterpipe study. MAPS Bulletin 6(3). Multidisciplinary Association for Psychedelic Studies 9–10–2008
Gieringer D, St. Laurent J, Goodrich S (2004) Cannabis vaporizer combines efficient delivery of THC with effective suppression of pyrolytic compounds. J Cannabis Ther 4:7–27
Giovanni A, Liang LP, Hastings TG et al (1995) Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J Neurochem 64:1819–1825
Giros B, Jaber M, Jones SR et al (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606–612
Giroud M, Dumas R (1994) Effect of smoking in cerebral vascular accidents. Presse Med 23:1037–1039
Gobbi G, Bambico FR, Mangieri R et al (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci USA 102:18620–18625
Greiner T, Burch NR, Edelberg R (1958) Psychopathology and psychophysiology of minimal LSD-25 dosage; a preliminary dosage-response spectrum. Arch Neurol Psychiatry 79:208–210
Gutierrez-Cebollada J, de la TR, Ortuno J et al (1994) Psychotropic drug consumption and other factors associated with heroin overdose. Drug Alcohol Depend 35:169–174
Halloran O, Ifthikharuddin S, Samkoff L (2005) Leukoencephalopathy from “chasing the dragon”. Neurology 64:1755
Harris RA, Trudell JR, Mihic SJ (2008) Ethanol’s molecular targets. Sci Signaling 1:e7
Hasler F, Bourquin D, Brenneisen R et al (1997) Determination of psilocin and 4-hydroxyindole acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharmacologica Acta Helvetica 72:175–184
Hattori K, Oomura Y, Akaike N (1986) Diazepam action on gamma-aminobutyric acid-activated chloride currents in internally perfused frog sensory neurons. Cell Mol Neurobiol 6:307–323
Hatzidimitriou G, McCann UD, Ricaurte GA (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/−)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19:5096–5107
Hazekamp A, Ruhaak R, Zuurman L et al (2006) Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. J Pharm Sci 95:1308–1317
Hemstapat K, Smith SA, Monteith GR et al (2003) The neuroexcitatory morphine metabolite, morphine-3-glucuronide (M3G), is not neurotoxic in primary cultures of either hippocampal or cerebellar granule neurones. Pharmacol Toxicol 93:197–200
Henningfield JE, Keenan RM (1993) Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol 61:743–750
Hilber B, Scholze P, Dorostkar MM et al (2005) Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines. Neuropharmacology 49:811–819
Hill MD, Cooper PW, Perry JR (2000) Chasing the dragon – neurological toxicity associated with inhalation of heroin vapour: case report. CMAJ Canadian Med Assoc J 162:236–238
Hobbs WR, Rall TW, Verdoorn TA (1996) Hypnotics and sedatives; ethanol. In: Hardman JG, Limbird LE (eds) Goodman & Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, New York, NY, pp 361–396
Hoffman PL, Rabe CS, Moses F et al (1989) N-Methyl-D-Aspartate receptors and ethanol – inhibition of calcium flux and cyclic-GMP production. J Neurochem 52:1937–1940
Hofmann A (1980) LSD-My problem child. McGraw-Hill, New York, NY
Hollister LE (1983) The pre-benzodiazepine era. J Psychoactive Drugs 15:9–13
Hollister LE (1986) Interactions of cannabis with other drugs in man. NIDA Res Monogr 68:110–116
Hotchkiss AJ, Gibb JW (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214:257–262
Huestis MA, Henningfield JE, Cone EJ (1992) Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 16:276–282
Hughes JR (2008) Smoking and suicide: a brief overview. Drug Alcohol Depend 98:169–178
Ikawa K, Watanabe A, Motohashi N et al (1994) The effect of repeated administration of methamphetamine on dopamine uptake sites in rat striatum. Neurosci Lett 167:37–40
Ikeda K, Kobayashi T, Kumanishi T et al (2002) Molecular mechanisms of analgesia iduced by opioids and ethanol: is the GIRK channel one of the keys? Neurosci Res 44:121–131
Isabelle M, Vergeade A, Moritz F et al (2007) NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction. J Mol Cell Cardiol 42:326–332
Isbell H, Wolbach Ab, Wikler A et al (1961) Cross tolerance between LSD and psilocybin. Psychopharmacologia 2:147–159
Jatlow PI (1987) Drug of abuse profile: cocaine. Clin Chem 33:Suppl-71B
Jiang W, Zhang Y, Xiao L et al (2005) Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest 115:3104–3116
Jones S, Kornblum JL, Kauer JA (2000) Amphetamine blocks long-term synaptic depression in the ventral tegmental area. J Neurosci 20:5575–5580
Kahlig KM, Binda F, Khoshbouei H et al (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci USA 102:3495–3500
Kalant H (1971) Absorption, diffusion, distribution, and elimination of ethanol. In: Kissin B, Begleiter H (eds) Effects on biological membranes in the biology of alcoholism. Plenum, New York, NY, pp 1–46
Kandel DB, Yamaguchi K, Chen K (1992) Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. J Stud Alcohol 53:447–457
Kilpatrick GJ, Smith TW (2005) Morphine-6-glucuronide: actions and mechanisms. Med Res Rev 25:521–544
King TS, Canez MS, Gaskill SG et al (1993) Chronic cocaine disruption of estrous cyclicity in the rat: dose-dependent effects. J Pharmacol Exp Ther 264:29–34
King TS, Schenken RS, Kang IS et al (1990) Cocaine disrupts estrous cyclicity and alters the reproductive. Neuroendocrinology 51:15–22
Kitamura S (1987) Effects of cigarette smoking on metabolic events in the lung. Environ Health Perspect 72:283–296
Klein TW, Newton C, Larsen K et al (2003) The cannabinoid system and immune modulation. J Leukoc Biol 74:486–496
Klous MG, Van den BW, Van Ree JM et al (2005) Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients. Drug Alcohol Depend 80:283–295
Kobayashi T, Ikeda K, Kojima H et al (1999) Ethanol opens G-protein-activated inwardly rectifying K+ channels. Nat Neurosci 2:1091–1097
Kogan NM, Mechoulam R (2007) Cannabinoids in health and disease. Dialogues Clin Neurosci 9:413–430
Konkol RJ (2008) Is there a cocaine baby syndrome? J Child Neurol 9:225–226
Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177–184
Koob GF (1992) Neural mechanisms of drug reinforcement. Ann NY Acad Sci 654:171–191
Kuczenski R, Segal D (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 9:2051–2065
LaBarre W (1975) The peyote cult. Archon Books, Hamden, CT
Lader M (1991) History of benzodiazepine dependence. J Subst Abuse Treat 8:53–59
Lamb RJ, Kirby KC, Morral AR et al (2004) Improving contingency management programs for addiction. Addict Behav 29:507–523
Lamb RJ, Morral AR, Kirby KC et al (2007) Contingencies for change in complacent smokers. Exp Clin Psychopharmacol 15:245–255
LaVoie MJ, Hastings TG (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci 19:1484–1491
Le Foll B, Goldberg SR (2005) Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence. J Pharmacol Exp Ther 312:875–883
Leith NJ, Kuczenski R (1981) Chronic amphetamine: tolerance and reverse tolerance reflect different behavioral actions of the drug. Pharmacol Biochem Behav 15:399–404
Lerman C, LeSage MG, Perkins KA et al (2007) Translational research in medication development for nicotine dependence. Nat Rev Drug Discov 6:746–762
Lewin L (1998) Indian hemp: cannabis Indica. Phantastica: a classic survey on the use and abuse of mind-altering plants. Park Street, Rochester, VT, pp 89–102
Lieber CS (1995) Medical disorders of alcoholism. NE J Med 333:1058–1065
Lieber CS (1999) Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968–1998) – a review. Alcoholism: Clin Exp Res 23:991–1007
Linszen D, van Amelsvoort T (2007) Cannabis and psychosis: an update on course and biological plausible mechanisms. Curr Opin Psychiatry 20:116–120
Lock M (1984) East Asian medicine in urban Japan: varieties of medical experience. University of California, Berkeley
Long H (2006) Inhalants. In: Flomenbaum NE, Goldfrank LR, Hoffman RS, Howland MA, Lewin NA, Nelson LS (eds) Goldfrank’s toxicologic emergencies. McGraw-Hill, New York, NY
Lopez-Munoz F, Ucha-Udabe R, Alamo C (2005) The history of barbiturates a century after their clinical introduction. Neuropsychiatr Dis Treat 1:329–343
Lovinger DM (1991) Inhibition of 5-Ht3 receptor-mediated ion current by divalent metal-cations in NCB-20 neuroblastoma-cells. J Neurophysiol 66:1329–1337
Lovinger DM, White G, Weight FF (1989) Ethanol inhibits NMDA-activated ion current in hippocampal-neurons. Science 243:1721–1724
Lubman DI, Yücel M, Lawrence AJ (2008) Inhalant abuse among adolescents: neurobiological considerations. Br J Pharmacol 154:316–326
Luddens H, Korpi ER, Seeburg PH (1995) GABAA/benzodiazepine receptor heterogeneity: neurophysiological implications. Neuropharmacology 34:245–254
Lynskey MT, Glowinski AL, Todorov AA et al (2004) Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Arch Gen Psychiatry 61:1026–1032
Malinski MK, Sesso HD, Lopez-Jiminez F et al (2004) Alcohol consumption and cardiovascular disease mortality in hypertensive men. Archiv Intern Med 164:623–628
Marek GJ, Aghajanian GK (1996) LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. J Pharmacol Exp Ther 278:1373–1382
Martin WR, Fraser HF (1961) A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts. J Pharmacol Exp Ther 133:388–399
McKim WA (1986) Cannabis. Drugs and behavior: an introduction to behavioral pharmacology. Prentice-Hall, Englewood Cliffs, NJ, pp 211–234
McKim WA (1986) Tobacco. Drugs and behavior: an introduction to behavioral pharmacology. Prentice-Hall, Englewood Cliffs, NJ, pp 125–143
Mechoulam R, Parker L (2003) Cannabis and alcohol – a close friendship. Trends Pharmacol Sci 24:266–268
Mellenby E (1919) Alcohol: its absorption into and disappearance from the blood under different conditions. Medical Research Council Special Report Service No. 31.
Mello NK, Sarnyai Z, Mendelson JH et al (1993) Acute effects of cocaine on anterior pituitary hormones in male and female rhesus monkeys. J Pharmacol Exp Ther 266:804–811
Mendelson J, Uemura N, Harris D et al (2006) Human pharmacology of the methamphetamine stereoisomers. Clin Pharmacol Ther 80:403–420
Messmer D, Hatsukari I, Hitosugi N et al (2006) Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation. Mol Med 12:284–290
Mihic SJ, Ye Q, Wick MJ et al (1997) Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 389:385–389
Miller AM, Stella N (2008) CB2 receptor-mediated migration of immune cells: it can go either way. Br J Pharmacol 153:299–308
Miller PM, Anton RF, Egan BM et al (2005) Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens 7:346–351
Mizoi Y, Ijiri I, Tatsuno Y et al (1979) Relationship between facial flushing and blood-acetaldehyde levels after alcohol intake. Pharmacol Biochem Behav 10:303–311
Monnet-Tschudi F, Hazekamp A, Perret N et al (2008) Delta-9-tetrahydrocannabinol accumulation, metabolism and cell-type-specific adverse effects in aggregating brain cell cultures. Toxicol Appl Pharmacol 228:8–16
Monte AP, Waldman SR, Marona-Lewicka D et al (1997) Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives. J Med Chem 40:2997–3008
Mooney M, Babb D, Jensen J et al (2005) Interventions to increase use of nicotine gum: a randomized, controlled, single-blind trial. Nicotine Tob Res 7:565–579
Moore KE (1977) The actions of amphetamine on neurotransmitters: a brief review. Biol Psychiatry 12:451–462
Moore RJ, Vinsant SL, Nader MA et al (1998) Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys. Synapse 30:88–96
Morin CM, Belanger L, Bastien C et al (2005) Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse. Behav Res Ther 43:1–14
Mura P, Kintz P, Dumestre V et al (2005) THC can be detected in brain while absent in blood. J Anal Toxicol 29:842–843
Murray RM, Morrison PD, Henquet C et al (2007) Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 8:885–895
Muschamp JW, Regina MJ, Hull EM et al (2004) Lysergic acid diethylamide and [–]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex. Brain Res 1023:134–140
Narahashi T, Aistrup GL, Lindstrom JM et al (1998) Ion channel modulation as the basis for general anesthesia. Toxicol Lett 101:185–191
National Drug Intelligence Center (2006). National Drug Threat Assessment. http://www.usdoj.gov. United States Department of Justice. Accessed 9 Oct 2008
Nichols DE (1986) Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoactive Drugs 18:1305–313
Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131–181
Nichols DE, Hoffman AJ, Oberlender RA et al (1986) Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class. J Med Chem 29:2009–2015
Norberg A, Gabrielsson J, Jones AW et al (2000) Within- and between-subject variations in pharmacokinetic parameters of ethanol by analysis of breath, venous blood, and urine. Br J Clin Pharmacol 49:399–408
Norman, V (1983) The History of Cigarettes
Obata T, Morelli M, Concas A, Serra M, Yamamura HI (1988) Modulation of GABA-stimulated chloride influx into membrane vesicles from rat cerebral cortex by benzodiazepines and nonbenzodiazepines. In: Biggio G, Costa E (eds) Chloride channels and their modulation by neurotransmitters and drugs. Raven, New York, NY, pp 175–187
Onaivi ES, Chakrabarti A, Chaudhuri G (1996) Cannabinoid receptor genes. Prog Neurobiol 48:275–305
ONDCP Public Affairs. Study Finds Highest Levels of THC in U.S. Marijuana To Date. whitehousedrugpolicy.gov. 5–1-0007. Office of National Drug Control Policy. 9–10–2008.
Owen RT, Tyrer P (1983) Benzodiazepine dependence. A review of the evidence. Drugs 25:385–398
Palazuelos J, Davoust N, Julien B et al (2008) The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis. J Biol Chem 283:13320–13329
Palenicek T, Balikova M, Bubenikova-Valesovas V et al (2008) Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose. Psychopharmacology 196:51–62
Papac DI, Foltz RL (1990) Measurement of lysergic acid diethylamide (LSD) in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry. J Anal Toxicol 14:189–190
Passie T, Seifert J, Schneider U et al (2002) The pharmacology of psilocybin. Addiction Biol 7:357–364
Patel RR, Ryu JH, Vassallo R (2008) Cigarette smoking and diffuse lung disease. Drugs 68:1511–1527
Patrick CH (1952) Alcohol, culture, and society. Duke University, Durham, NC
Patrick RL (1977) Amphetamine and cocaine: biological mechanisms. In: Barchas JD, Berger PA, Ciaranello RD (eds) Psychopharmacology: from theory to practice. Oxford University, New York, NY, pp 331–340
Patton GC, Hibbert M, Rosier MJ et al (1995) Patterns of common drug use in teenagers. Aust J Public Health 19:393–399
Peat MA, Warren PF, Bakhit C et al (1985) The acute effects of methamphetamine, amphetamine and p-chloroamphetamine on the cortical serotonergic system of the rat brain: evidence for differences in the effects of methamphetamine and amphetamine. Eur J Pharmacol 116:11–16
Pelner L (1967) Peyote cult, mescaline hallucinations, and model psychosis. NY State J Med 67:2838–2843
Perez J, Ribera MV (2008) Managing neuropathic pain with Sativex: a review of its pros and cons. Expert Opin Pharmacother 9:1189–1195
Perrine DM (1996) Dissociatives and cannabinoids: PCP, THC, ETCs. The chemistry of mind-altering drugs: history, pharmacology, and cultural context. American Chemical Society, Washington, DC, pp 338–369
Perrine DM (1996) Stimulants: nicotine, caffeine, cocaine, amphetamines. The chemistry of mind-altering drugs: history, pharmacology, and cultural context. American Chemical Society, Washington, DC, pp 172–179
Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129–180
Picciotto MR, Addy NA, Mineur YS et al (2008) It is not “either/or”: activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol 84:329–342
Popkin MK (2008) Exacerbation of recurrent depression as a result of treatment with varenicline. Am J Psychiatry 165:774
Poyares D, Guilleminault C, Ohayon MM et al (2004) Chronic benzodiazepine usage and withdrawal in insomnia patients. J Psychiatr Res 38:327–334
Reith ME (1988) Cocaine receptors on monoamine transporters and sodium channels. NIDA Res Monogr 88:23–43
Ricaurte GA, DeLanney LE, Irwin I et al (1988) Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res 446:165–168
Ricaurte GA, DeLanney LE, Wiener SG et al (1988) 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates. Brain Res 474:359–363
Ricaurte GA, Martello AL, Katz JL et al (1992) Lasting effects of (±)-3,4-methyle-nedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J Pharmacol Exp Ther 261:616–622
Rickert WS, Robinson JC, Rogers B (1982) A comparison of tar, carbon monoxide and pH levels in smoke from marihuana and tobacco cigarettes. Can J Public Health 73:386–391
Riddle EL, Fleckenstein AE, Hanson GR (2006) Mechanisms of methamphetamine-induced dopaminergic neurotoxicity. AAPS J 8:E413–E418
Robertson B (1989) Actions of anaesthetics and avermectin on GABAA chloride channels in mammalian dorsal root ganglion neurones. Br J Pharmacol 98:167–176
Robledo-Carmona J, Ortega-Jimenez MV, Garcia-Pinilla JM et al (2006) Severe cardiomyopathy associated to cocaine abuse. Int J Cardiol 112:130–131
Rold JF (1986) Mushroom madness. Psychoactive fungi and the risk of fatal poisoning. Postgraduate Med 79:218–228
Rose JS (1994) Cocaethylene: a current understanding of the active metabolite of cocaine and ethanol. Am J Emergency Med 12:489–490
Roth D, Alarcon FJ, Fernandez JA et al (1988) Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med 319:673–677
Rothman RB, Baumann MH (2006) Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann NY Acad Sci 1074:245–260
Sasco AJ, Merrill RM, Dari I et al (2002) A case-control study of lung cancer in Casablanca, Morocco. Cancer Causes Control 13:609–616
Savaki HE, Cunha J, Carlini EA et al (1976) Pharmacological activity of three fractions obtained by smoking cannabis through a water pipe. Bull Narc 28:49–56
Sawynok J (1986) The therapeutic use of heroin: a review of the pharmacological literature. Can J Physiol Pharmacol 64:1–6
Schepers RJ, Oyler JM, Joseph RE Jr et al (2003) Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem 49:121–132
Schwartz RH (1988) Mescaline: a survey. Am Family Physician 37:122–124
Seivewright N, Dougal W (1993) Withdrawal symptoms from high dose benzodiazepines in poly drug users. Drug Alcohol Depend 32:15–23
Self DW, Belluzzi JD, Kossuth S et al (1996) Self-administration of the D1 agonist SKF 82958 is mediated by D1, not D2, receptors. Psychopharmacology 123:303–306
Seliskar M, Rozman D (2007) Mammalian cytochromes P450 – importance of tissue specificity. Biochim Biophys Acta 1770:458–466
Signs SA, Ckey-White HI, Vanek VW et al (1996) The formation of cocaethylene and clinical presentation of ED patients testing positive for the use of cocaine and ethanol. Am J Emergency Med 14:665–670
Simmonds MA (1981) Distinction between the effects of barbiturates, benzodiazepines and phenytoin on responses to gamma-aminobutyric acid receptor activation and antagonism by bicuculline and picrotoxin. Br J Pharmacol 73:739–747
Slikker W Jr, Holson RR, Ali SF et al (1989) Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. Neurotoxicology 10:529–542
Slotkin TA (2008) If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents? Neurotoxicol Teratol 30:1–19
Smith DE, Wesson DR (1971) Phenobarbital technique for treatment of barbiturate dependence. Arch Gen Psychiatry 24:56–60
Stephans S, Yamamoto B (1996) Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity. Neuroscience 72:593–600
Strandberg JJ, Kugelberg FC, Alkass K et al (2006) Toxicological analysis in rats subjected to heroin and morphine overdose. Toxicol Lett 166:11–18
Sulzer D, Chen TK, Lau YY et al (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102–4108
Sulzer D, Sonders MS, Poulsen NW et al (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406–433
Svenningsson P, Nairn AC, Greengard P (2005) DARPP-32 mediates the actions of multiple drugs of abuse. AAPS J 7:E353–E360
Symm B, Morgan MV, Blackshear Y et al (2005) Cigar smoking: an ignored public health threat. J Prim Prev 26:363–375
Tashkin DP, Gliederer F, Rose J et al (1991) Tar, CO and delta 9THC delivery from the 1st and 2nd halves of a marijuana cigarette. Pharmacol Biochem Behav 40:657–661
Tazelaar HD, Karch SB, Stephens BG et al (1987) Cocaine and the heart. Human Pathol 18:195–199
Tschacher W, Haemmig R, Jacobshagen N (2003) Time series modeling of heroin and morphine drug action. Psychopharmacology 165:188–193
Van DC, Barash PG, Jatlow P et al (1976) Cocaine: plasma concentrations after intranasal application in man. Science 191:859–861
Vaughan CW, Christie MJ (2005) Retrograde signalling by endocannabinoids. Handb Exp Pharmacol 168:367–383
Vengeliene V, Bilbao A, Molander A et al (2008) Neuropharmacology of alcohol addiction. Br J Pharmacol 154:299–315
Virmani R, Robinowitz M, Smialek JE et al (1988) Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J 115:1068–1076
Voirin N, Berthiller J, Benhaïm-Luzon V et al (2006) Risk of lung cancer and past use of cannabis in Tunisia. J Thorac Oncol 1:577–579
Volpe FH (1992) Effect of cocaine use on the fetus. N Engl J Med 327:399–407
von Anrep B (208) Ueber die physiologische Wirkung des Cocain. E Pfluger Arch Ges Physiol 21:38–77
von Bibra BEF (1995) Hashish. Plant Intoxicants: a classic text on the use of mind-altering plants. Healing Arts, Rochester, VT, pp 147–165
von Bibra BEF (1995) Tobacco. Plant Intoxicants: a classic text on the use of mind-altering plants. Healing Arts, Rochester, VT, pp 165–206
Wallner M, Olsen RW (2008) Physiology and pharmacology of alcohol: the imidazobenzodiazepine alcohol antagonist site on subtypes of GABAA receptors as an opportunity for drug development. Br J Pharmacol 154:288–298
Wang XM, Wang G, Lemos JR et al (1994) Ethanol directly modulates gating of a dihydropyridine-sensitive Ca2+ channel in neurohypophyseal terminals. J Neurosci 14:5453–5460
Warner KE (2005) Will the next generation of “safer” cigarettes be safer? J Pediatr Hematol Oncol 27:543–550
White JM, Irvine RJ (1999) Future directions in opioid overdose. Addiction 94:978–980
Wikler A (1968) Diagnosis and treatment of drug dependence of the barbiturate type. Am J Psychiatry 125:758–765
Wilcox HC, Anthony JC (2004) The development of suicide ideation and attempts: an epidemiologic study of first graders followed into young adulthood. Drug Alcohol Depend 76 Suppl:S53–S67
Wilkes S (2008) The use of bupropion SR in cigarette smoking cessation. Int J Chron Obstruct Pulmon Dis 3:45–53
Wilkinson PK (1980) Pharmacokinetics of ethanol: a review. Alcoholism: Clin Exp Res 4:6–21
Wilkinson PK, Sedman AJ, Sakmar E et al (1977) Pharmacokinetics of ethanol after oral administration in the fasting state. J Pharmacokinet Biopharm 5:207–224
Willems EW, Rambali B, Vleeming W et al (2006) Significance of ammonium compounds on nicotine exposure to cigarette smokers. Food Chem Toxicol 44:678–688
Williams RT (1959) Detoxication mechanisms. Wiley, New York
Williams RT, Caldwell RJ, Dreng LG (1973) Comparative metabolism of some amphetamines in various species. In: Schneider SH, Esdin E (eds) Frontiers of catecholamine research. Pergamon, Oxford, England, pp 927–932
Winger G, Hofmann FG, Woods JH (1992) A handbook on drug and alcohol abuse. University Press, New York, Oxford
Wittman M, Carter O, Hasler F et al (2007) Effects of psilocybin on time perception and temporal control of behavior in humans. J Psychopharmacol 21:50–64
Wu TC, Tashkin DP, Rose JE et al (1988) Influence of marijuana potency and amount of cigarette consumed on marijuana smoking pattern. J Psychoactive Drugs 20:43–46
Yamamoto BK, Zhu W (1998) The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 287:107–114
Yu R, Ticku MK (1995) Effects of chronic pentobarbital treatment on the GABAA receptor complex in mammalian cortical neurons. J Pharmacol Exp Ther 275:1442–1446
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Javors, M.A., King, T.S., Ginsburg, B.C., Gerak, L.R. (2010). Neurobehavioral Toxicology of Substances of Abuse. In: Johnson, B. (eds) Addiction Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0338-9_14
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0338-9_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0337-2
Online ISBN: 978-1-4419-0338-9
eBook Packages: MedicineMedicine (R0)